Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gloria Lau

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
BMC Pulmonary Medicine|December 29, 2022
Change in health outcomes for First Nations children with chronic wet cough: rationale and study protocol for a multi-centre implementation science studyPamela J Laird, Roz Walker, Gabrielle McCallum, et al.
Biochemical Pharmacology|July 4, 2006
Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4Simon P Fricker, Virginia Anastassov, Jennifer Cox, et al.
Journal of the American Chemical Society|September 28, 2011
Prospective CCR5 small molecule antagonist compound design using a combined mutagenesis/modeling approachMarkus Metz, Elyse Bourque, Jean Labrecque, et al.
Virology|March 11, 2011
HIV-1 entry inhibition by small-molecule CCR5 antagonists: a combined molecular modeling and mutant study using a high-throughput assayJean Labrecque, Markus Metz, Gloria Lau, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2011
Design and synthesis of pyridin-2-yloxymethylpiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 14, 2022
Genetic Mapping of APP and Amyloid-β Biology Modulation by Trisomy 21Paige Mumford, Justin Tosh, Silvia Anderle, et al.
Pediatric Pulmonology|September 13, 2022
Prevalence of chronic respiratory diseases in Aboriginal children: A whole population studyPamela Laird, Nicola Ball, Shekira Brahim, et al.
Biochemical Pharmacology|December 8, 2011
The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitorRenee M Mosi, Virginia Anastassova, Jennifer Cox, et al.
Journal of Inorganic Biochemistry|August 8, 2008
Metal compounds for the treatment of parasitic diseasesSimon P Fricker, Renee M Mosi, Beth R Cameron, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 21, 2026
Age-related behavioral and molecular landmarks in new mouse models for studying Alzheimer's disease in Down syndromeMonika Rataj Baniowska, Paige Mumford, Francesca Prestia, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
BMC Pulmonary Medicine|December 29, 2022
Change in health outcomes for First Nations children with chronic wet cough: rationale and study protocol for a multi-centre implementation science studyPamela J Laird, Roz Walker, Gabrielle McCallum, et al.
Biochemical Pharmacology|July 4, 2006
Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4Simon P Fricker, Virginia Anastassov, Jennifer Cox, et al.
Journal of the American Chemical Society|September 28, 2011
Prospective CCR5 small molecule antagonist compound design using a combined mutagenesis/modeling approachMarkus Metz, Elyse Bourque, Jean Labrecque, et al.
Virology|March 11, 2011
HIV-1 entry inhibition by small-molecule CCR5 antagonists: a combined molecular modeling and mutant study using a high-throughput assayJean Labrecque, Markus Metz, Gloria Lau, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2011
Design and synthesis of pyridin-2-yloxymethylpiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 14, 2022
Genetic Mapping of APP and Amyloid-β Biology Modulation by Trisomy 21Paige Mumford, Justin Tosh, Silvia Anderle, et al.
Pediatric Pulmonology|September 13, 2022
Prevalence of chronic respiratory diseases in Aboriginal children: A whole population studyPamela Laird, Nicola Ball, Shekira Brahim, et al.
Biochemical Pharmacology|December 8, 2011
The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitorRenee M Mosi, Virginia Anastassova, Jennifer Cox, et al.
Journal of Inorganic Biochemistry|August 8, 2008
Metal compounds for the treatment of parasitic diseasesSimon P Fricker, Renee M Mosi, Beth R Cameron, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 21, 2026
Age-related behavioral and molecular landmarks in new mouse models for studying Alzheimer's disease in Down syndromeMonika Rataj Baniowska, Paige Mumford, Francesca Prestia, et al.
Pageof 3